Documentation Centre

 

 

  of 318 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Metabolic inflammation-a role for hepatic inflammatory pathways as drivers of comorbidities in nonalcoholic fatty liver disease? Gastroenterology. 2020;158:1929-1947. August 06, 2020 Metabolic inflammation-a role for hepatic inflammatory pathways as drivers of comorbidities in nonalcoholic fatty liver disease? Gastroenterology. 2020;158:1929-1947. Gehrke N, Schattenberg JM Key Publications
Adipose tissue-liver cross talk in the control of whole-body metabolism: Implications in nonalcoholic fatty liver disease. Gastroenterology. 2020;158:1899-1912. August 06, 2020 Adipose tissue-liver cross talk in the control of whole-body metabolism: Implications in nonalcoholic fatty liver disease. Gastroenterology. 2020;158:1899-1912. Azzu V, Vacca M, Virtue S, Allison M, Vidal-Puig A Key Publications
Metabolism of lipoprotein(a): new findings, implications and outstanding issues. Curr Opin Lipidol. 2020;31:163-165. July 27, 2020 Metabolism of lipoprotein(a): new findings, implications and outstanding issues. Curr Opin Lipidol. 2020;31:163-165. Chan DC, Watts GF Key Publications
Regulation of lipoprotein lipase-mediated lipolysis of triglycerides. Curr Opin Lipidol. 2020;31:154-160. July 27, 2020 Regulation of lipoprotein lipase-mediated lipolysis of triglycerides. Curr Opin Lipidol. 2020;31:154-160. Basu D, Goldberg IJ Key Publications
Lean NAFLD: A distinct entity shaped by differential metabolic adaptation. Hepatology. 2020;71:1213-1227 June 23, 2020 Lean NAFLD: A distinct entity shaped by differential metabolic adaptation. Hepatology. 2020;71:1213-1227 Chen F, Esmaili S, Rogers GB, Bugianesi E, Petta S, Marchesini G, Bayoumi A, Metwally M, Azardaryany MK, Coulter S, Choo JM, Younes R, Rosso C, Liddle C, Adams LA, Craxì A, George J, Eslam M Key Publications
Importance of intensive blood pressure control in type 2 diabetes: Mechanisms, treatments and current guidelines. Diabetes Obes Metab. 2020;22 2:33-42 June 22, 2020 Importance of intensive blood pressure control in type 2 diabetes: Mechanisms, treatments and current guidelines. Diabetes Obes Metab. 2020;22 2:33-42 Marre M Key Publications
High-density lipoproteins are the main carriers of PCSK9 in the circulation. J Am Coll Cardiol. 2020;75:1495-1497 June 16, 2020 High-density lipoproteins are the main carriers of PCSK9 in the circulation. J Am Coll Cardiol. 2020;75:1495-1497 Burnap SA, Joshi A, Tsimikas S, Fernández-Hernando C, Kiechl S, Berry SE, Hall W, Levkau B, Mayr M Key Publications
Type 2 diabetes influences bacterial tissue compartmentalisation in human obesity. Nature Metabolism 2020:2;233-242 June 15, 2020 Type 2 diabetes influences bacterial tissue compartmentalisation in human obesity. Nature Metabolism 2020:2;233-242 Anhê FF, Anderschou Holbech Jensen B, Varin TV, Servant F, Van Blerk S, Richard D, Marceau S, Surette M, Biertho L, Lelouvier B, Schertzer JD, Tchernof A, Marette A Key Publications
Microbial signatures in metabolic tissues: a novel paradigm for obesity and diabetes? Nature Metabolism volume 2020:2;211–212 June 12, 2020 Microbial signatures in metabolic tissues: a novel paradigm for obesity and diabetes? Nature Metabolism volume 2020:2;211–212 Cani PD, Van Hul M Key Publications
Conversion of a dietary fructose: new clues from the gut microbiome. Nature Metabolism 2020:2;217–218 June 12, 2020 Conversion of a dietary fructose: new clues from the gut microbiome. Nature Metabolism 2020:2;217–218 Postic C Key Publications

  of 318 Next page

Go to page: of